Ashwagandha and Fluoxetine Co-administration
No high-quality evidence demonstrates that ashwagandha is safe with fluoxetine (Prozac). [1]
Caution is recommended because ashwagandha has documented adverse effects and has some potential for medication interactions, while fluoxetine has clinically important interaction warnings (including serotonin toxicity risk with other serotonergic agents). [1] [2]
Interaction Evidence Availability
NCCIH reports that there is evidence that ashwagandha might interact with some medications, while also emphasizing limited information for many supplement–drug combinations. [1] [3]
No well-supported clinical trials establish the safety of the specific combination of ashwagandha and fluoxetine. [1]
Pharmacology and Safety Considerations Relevant to Fluoxetine
Fluoxetine is a potent CYP2D6 inhibitor. [2]
Fluoxetine labeling advises caution when fluoxetine is coadministered with drugs that may affect serotonergic neurotransmitter systems due to the potential for serotonin syndrome. [2]
Because the supplement–drug interaction profile of ashwagandha is not fully characterized, monitoring is required if used concurrently. [1] [3]
Ashwagandha Adverse Effects Relevant to Concomitant Use
Ashwagandha preparations may cause drowsiness, stomach upset, diarrhea, and vomiting in some individuals. [1]
Although rare, ashwagandha has been linked to cases of liver injury. [1]
Ashwagandha should be avoided during pregnancy and should not be used while breastfeeding. [1]
Ashwagandha is not recommended in people with autoimmune or thyroid disorders and in people about to have surgery. [1]
Practical Risk-Control Recommendations
Ashwagandha use with fluoxetine should be treated as a medication-level exposure requiring clinician awareness and monitoring. [1] [3]
If concurrent use occurs, monitoring should include assessment for serotonergic toxicity symptoms (such as agitation, confusion, fever, sweating, tremor, diarrhea, and muscle rigidity) given fluoxetine’s serotonin syndrome warning context. [2]
Monitoring should also include assessment for hepatotoxicity symptoms and discontinuation consideration if liver injury is suspected, given the reported (rare) link between ashwagandha and liver injury cases. [1]
When to Avoid the Combination
Ashwagandha should be avoided in individuals where NCCIH contraindicates or discourages ashwagandha use, including pregnancy, breastfeeding, autoimmune or thyroid disorders, and the perioperative period. [1]
The combination should be avoided if any other medication that is known to increase serotonergic risk (relative to fluoxetine labeling cautions) is being added without prescriber coordination. [2]
Reported Herb–Antidepressant Interaction Signal
A retrospective chart review of adaptogen–antidepressant adverse event reports identified fluoxetine among antidepressants with reported adaptogen-associated adverse effects, supporting the need for pharmacovigilance when combining adaptogens with antidepressants. [4]
Signs Requiring Urgent Medical Attention
Urgent evaluation is indicated for features consistent with serotonin syndrome in the setting of fluoxetine therapy. [2]
Urgent evaluation is indicated for possible liver injury in the setting of ashwagandha exposure, including jaundice, dark urine, severe fatigue, or right-upper-quadrant abdominal pain. [1]
Key Medication-Management Steps
All supplements and doses should be disclosed to the treating clinician to support interaction screening and monitoring. [3]
Supplement quality varies because dietary supplements are not regulated like prescription drugs before marketing, which can increase unpredictability of exposure and adverse effects. [1]
If ashwagandha is used, the lowest effective dose for the shortest duration should be selected under clinician guidance to reduce adverse-effect risk. [1]